HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Established and experimental medical therapy of pulmonary sarcoidosis.

Abstract
The treatment options for pulmonary sarcoidosis have increased over the past 10 years. As new treatments have been introduced, the best way to assess and compare treatments remains unknown. The goal of this review is to discuss the standard treatments for pulmonary sarcoidosis, including glucocorticoids, and cytotoxic agents, such as methotrexate, azathioprine and leflunomide, and compare them to the newer biological agents, such as infliximab and adalimumab. We also discuss some novel treatments which are currently being evaluated. To compare these different regimens, we look at the measures used to assess response. These include pulmonary function, chest imaging, steroid sparing potential and, more recently, improvements in quality of life measures. While there is, as yet, no standard assessment for response, there is a growing consensus that response to treatment may include improvement of one or more of the following: forced vital capacity, chest imaging and steroid sparing. Several drugs used for pulmonary sarcoidosis have demonstrated improvement in one or more of these measures.
AuthorsRobert P Baughman, Hilario Nunes, Nadera J Sweiss, Elyse E Lower
JournalThe European respiratory journal (Eur Respir J) Vol. 41 Issue 6 Pg. 1424-38 (Jun 2013) ISSN: 1399-3003 [Electronic] England
PMID23397302 (Publication Type: Comparative Study, Journal Article, Review)
Chemical References
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Glucocorticoids
  • Immunosuppressive Agents
  • Isoxazoles
  • Infliximab
  • Adalimumab
  • Leflunomide
  • Azathioprine
  • Methotrexate
Topics
  • Adalimumab
  • Antibodies, Monoclonal (therapeutic use)
  • Antibodies, Monoclonal, Humanized (therapeutic use)
  • Azathioprine (therapeutic use)
  • Clinical Trials as Topic
  • Dyspnea (diagnosis)
  • Glucocorticoids (therapeutic use)
  • Humans
  • Immunosuppressive Agents (therapeutic use)
  • Infliximab
  • Isoxazoles (therapeutic use)
  • Leflunomide
  • Methotrexate (therapeutic use)
  • Positron-Emission Tomography
  • Quality of Life
  • Radiography, Thoracic
  • Research Design
  • Respiratory Function Tests
  • Sarcoidosis, Pulmonary (diagnosis, drug therapy)
  • Therapies, Investigational
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: